A study comparing lenvatinib plus drug-eluting bead transarterial chemoembolization with and without hepatic arterial infusion chemotherapy for hepatocellular carcinoma > 7.0 cm with major portal vein tumor thrombosis found that the addition of haic significantly improved objective response rate, time to progression, and overall survival, with a comparable safety profile.
Journal Article by Cai M, Liang L (…) Zhu K et 13 al. in Int J Surg
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.